Study S000421

The Timing for Liraglutide in Patients Remaining Obese at 6 Months After Metabolic Surgery: an Observational Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07374445
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 100
Start: 2023-09-01
Primary completion: 2025-06-01
Lead sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions: Obesity; Weight Loss; Bariatric Surgery
Interventions: DRUG:Liraglutide injection; BEHAVIORAL:Diet and exercise guidelines
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in %TWL from baseline to endpoint across patient groups [48 weeks from enrollment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.